Luzich Partners Releases Open Letter To Columbia Laboratories, Inc. Shareholders

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Dear Fellow Columbia Laboratories Shareholders:

Since we made our letter to the Columbia Laboratories (“Columbia” or the “Company”) board (the “Board”) public on December 9, 2013, several shareholders have contacted us to express their agreement with the views we articulated and various postings have been made in public message boards voicing their authors’ frustration with the Board. Not a single outside shareholder has reached out to us to defend the Company’s current strategy and the Company’s deafening silence has, in our opinion, revealed the Board’s lack of concern for the shareholders to whom it owes a fiduciary duty. We believe that change is inevitable at Columbia and that the growing momentum of shareholder discontent will be too overwhelming for the Board to ignore.

Help employers find you! Check out all the jobs and post your resume.

Back to news